Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons dr. J.M. Meijer

Publicaties

Bullous pemphigoid outcome measurement: a scoping review of outcome heterogeneity and trends in clinical research of treatments

Clinical phenotype transition in pemphigus may suggest undertreatment with rituximab: findings from a retrospective single-centre analysis of relapsed patients

Emerging Treatments in Pemphigus: Is Healing an Achievable Goal?

European S2k guidelines on management of autoimmune blistering diseases in children and adolescents

International development of Investigator Global Assessment scores for pemphigus

Navigating challenges in clinical trials for bullous pemphigoid and pemphigus: learnings from the clinical trial graveyard and an international expert survey

Patient Perspectives on Treatment Outcomes and Priorities in Autoimmune Bullous Diseases:: An Exploratory Survey among Dutch Patients

Rituximab resistant pemphigus vulgaris successfully treated with obinutuzumab

VEXAS syndrome as an underlying cause of disease in patients with Sweet syndrome

Bullous and Nonbullous Pemphigoid Associated With Prurigo Nodularis: Successful Treatment With Dupilumab

Pers/media

VEXAS: je ziet het pas als je het doorhebt

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijnSDG 17 - Partnerschap om de doelen te bereiken

Meer informatie over de Sustainable Development Goals.